RNAs were obtained from cells using the RNeasy Mini kit (Qiagen, Valencia, CA, USA), and cDNAs were generated using SuperScript III First Strand Kits (Invitrogen). Quantitative PCR was conducted using LightCycler 480 SYBR Green I Master kit (Roche Life Science). All assays were run in duplicate for three or four individual samples. Relative expression levels were calculated using the ΔCt method, normalizing to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcription. The PCR products were verified by melting curve analysis and/or 2% agarose gel electrophoresis. The specific primers were designed as follows: ABCG2, For, 5′-TGGCTTAGACTCAAGCACAGC-3′, Rev, 5′-TCGTCCCTGCTTAGACATCC-3′; BMI-1, For, 5′-CTGGTTGCCCATTGACAGC-3′, Rev, 5′-CAGAAAATGAATGCGAGCCA-3′; CK19, For, 5′-CTGCGGGACAAGATTCTTGGT-3′, Rev, 5′-CAGAAAATGAATGCGAGCCA-3′; ΔNp63, For, 5′-CTGGAAAACAATGCCCAGAC-3′, Rev, 5′-GGGTGATGGAGAGAGAGCAT-3′; KRT14, For, 5′-TCCGCACCAAGTATGAGACA-3′, Rev, 5′-GGCTCTCAATCTGCATCTCC-3′; HES1, For, 5′-GCGGACATTCTGGAAATGACA-3′, Rev, 5′-AGCGCAGCCGTCATCTG-3′; GAPDH, For, 5′-GCCAAGGTCATCCATGACAAC-3′, Rev, 5′-GTCCACCACCCTGTTGCTGTA-3′; Tp63, Cat. no. PPH01032E (SABiosciences, Frederick, MD, USA).